Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis
Public ClinicalTrials.gov record NCT00384098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel-group, 4-arm, 12-week Study to Evaluate the Safety and Efficacy of Topically Applied CTA018 vs Vehicle for the Treatment of Adult Subjects With Chronic Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Vitamin D and its analogs are currently widely used for the treatment of psoriasis. The study drug (CTA018) is a novel analog of vitamin D, and this Phase 2 study will investigate the efficacy and safety of CTA018 in the treatment of psoriasis. Patients with chronic plaque psoriasis will receive one of three doses of CTA018 cream or vehicle (no study drug) daily for 12 weeks.
Study identification
- NCT ID
- NCT00384098
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2006
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Sep 28, 2014
2006 – 2007
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Tucson | Arizona | 85710 | — |
| Dermatology Research of Arkansas PLLC | Little Rock | Arkansas | 72205 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Radiant Research, Kansas City | Overland Park | Kansas | 66215 | — |
| Mass General/ Brigham & Women's | Boston | Massachusetts | 02215 | — |
| Department of Dermatology, Mayo Clinic | Rochester | Minnesota | 55905 | — |
| UMDNJ-Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08903 | — |
| New York University Medical Center | New York | New York | 10016 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Buffalo Medical Group PC | Williamsville | New York | 14221 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Radiant Research | Cincinnati | Ohio | 45249 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | — |
| Paddington Testing Co. | Philadelphia | Pennsylvania | 19103 | — |
| Radiant Research Inc. | Anderson | South Carolina | 29621 | — |
| Palmetto Clinical Trial Services LLC | Greenville | South Carolina | 29607 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00384098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2014 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00384098 live on ClinicalTrials.gov.